Topic

Nucala (mepolizumab)

A collection of 30 issues

Blue Cross Blue Shield Illinois Coverage Criteria for Nucala (Mepolizumab): What Counts as "Medically Necessary"?

Quick Answer: Getting Nucala Covered by Blue Cross Blue Shield in Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Nucala with specific medical necessity criteria: blood eosinophil count ≥150 cells/μL (recent) or ≥300 cells/μL (past year), documented severe eosinophilic asthma despite 3+ months of high-dose

How to Get Nucala (Mepolizumab) Covered by Humana in California: Complete Timeline, Forms & Appeals Guide

Answer Box: Getting Nucala Covered by Humana in California Humana requires prior authorization for Nucala (mepolizumab) with a 7-day standard decision timeline starting January 2025. Key requirements: blood eosinophil count ≥150 cells/μL, severe asthma despite 3+ months of optimized inhaled therapy, and age ≥6 years. Submit via CoverMyMeds or

Renewing Nucala (Mepolizumab) Approval with Humana in Georgia: Complete Timeline and Documentation Guide

Answer Box: Renewing Nucala with Humana in Georgia Humana requires prior authorization renewal for Nucala (mepolizumab) every 6-12 months with updated clinical documentation. Start the renewal process 30-60 days before your current authorization expires. You'll need recent eosinophil counts, asthma control scores, and evidence of continued clinical benefit.

How to Get Nucala (Mepolizumab) Covered by Humana in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Nucala Covered by Humana in Florida Nucala (mepolizumab) requires prior authorization from Humana with specific criteria: blood eosinophil count ≥150 cells/μL within 6 weeks, severe asthma despite 3+ months of optimized therapy, and age ≥6 years. Fastest approval path: Submit via CoverMyMeds with complete clinical documentation.

How to Get Nucala (Mepolizumab) Covered by Blue Cross Blue Shield of California: 2024 Prior Authorization Guide

Answer Box: Getting Nucala Covered by Blue Shield of California Blue Shield of California requires prior authorization for Nucala (mepolizumab) with specific criteria: eosinophil count >150 cells/µL (6 weeks) or >300 cells/µL (12 months), failed high-dose inhaled corticosteroids plus controller for 3+ months, and prescription by

UnitedHealthcare's Coverage Criteria for Nucala (mepolizumab) in Texas: What Counts as "Medically Necessary"?

Answer Box: Getting Nucala Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Nucala (mepolizumab) with specific criteria: eosinophil count ≥150 cells/µL (or ≥300 cells/µL in past year) for severe asthma, documented failure of high-dose inhaled therapy, and specialist involvement. Fastest path: Submit PA through UnitedHealthcare Provider

How to Get Nucala (Mepolizumab) Covered by Blue Cross Blue Shield in Pennsylvania: 2024 Appeals Guide

Answer Box: Getting Nucala Covered in Pennsylvania To get Nucala (mepolizumab) covered by Blue Cross Blue Shield in Pennsylvania: Your doctor must submit a prior authorization request with blood eosinophil count ≥150 cells/µL, proof of severe eosinophilic asthma uncontrolled on high-dose ICS/LABA therapy, and exacerbation history. If denied,

How Long Does It Take to Get Nucala (Mepolizumab) Approved by Blue Cross Blue Shield in Texas? Complete Timeline & Appeals Guide

Answer Box: Getting Nucala Approved in Texas Blue Cross Blue Shield of Texas typically takes 3-15 business days to approve Nucala (mepolizumab) with complete documentation. Fastest path: Submit prior authorization through your specialist with eosinophil count ≥150 cells/μL, documented exacerbations, and evidence of failed step therapy alternatives. Start today:

Get Nucala (Mepolizumab) Covered by Blue Cross Blue Shield North Carolina: Complete Prior Authorization & Appeals Guide

Answer Box: Quick Path to Nucala Coverage To get Nucala covered by Blue Cross Blue Shield North Carolina: You need prior authorization with blood eosinophils ≥150 cells/μL, documented severe asthma with ≥2 exacerbations despite high-dose inhaled therapy, and specialist involvement. Submit through the Blue e portal with complete clinical

How to Get Nucala (Mepolizumab) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Nucala Covered by Cigna in Michigan Cigna requires prior authorization for Nucala (mepolizumab) in Michigan with specific eosinophil count criteria (≥300 cells/µL) and step therapy requirements. You'll likely need to try benralizumab or dupilumab first unless contraindicated. If denied, Michigan's DIFS external